Enterobacteriaceae
BCID2 Panel Significantly Reduces Time to Appropriate Therapy in Gram-Negative BSIs
Implementation of the BioFire FilmArray BCID2 (bioMérieux) resulted in clinically significant reduced time ...
AUGUST 6, 2025
Better Tools for Fighting Gram-Negative Infections, but More Are Needed
Multidrug-resistant gram-negative bacteria are difficult to treat, but FDA approvals have increased the clinical ...
FEBRUARY 27, 2025
Cefiderocol May Be Game Changer for Acinetobacter
Cefiderocol may be a game changer for treating resistant Acinetobacter in patients with limited or no alternative ...
FEBRUARY 21, 2025
mcr-1 Found in Michigan
A Michigan survey of colistin resistance in Enterobacteriaceae identified a number of colistin-resistant isolates, ...
JULY 30, 2019
IMI/REL Shows Promise Against Drug-Resistant Infections
Merck's investigational combination relebactam-imipenem may fill a critical void in therapies effective against ...
SEPTEMBER 11, 2018
